Molecular Diagnostics and Tumor Mutational Analysis

作者: Melissa A. Wilson , Katherine L. Nathanson

DOI: 10.1007/978-1-4939-2143-0_3

关键词:

摘要: Genetic and genomic analysis of melanoma tumor samples has identified a number somatic mutations integral to pathogenesis, with the most prevalent mutation being BRAF V600 mutation. Targeted inhibitors directed against this have produced improved overall survival compared chemotherapy. Multiple additional been identified, some also prompted development therapy targeted them. In chapter, we review common techniques used identify gene aberrations, briefly describe important in pathogenesis. We massively parallel sequencing discuss advances that made identification novel driver tumors. Finally, application these respect clinical testing is addressed, specifically as they pertain advancement personalized medicine.

参考文章(123)
Ulrike Leiter, Claus Garbe, Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. Advances in Experimental Medicine and Biology. ,vol. 624, pp. 89- 103 ,(2008) , 10.1007/978-0-387-77574-6_8
B. Van Houten, M. Kong, Eukaryotic Nucleotide Excision Repair Reference Module in Biomedical Sciences#R##N#Encyclopedia of Cell Biology. pp. 435- 441 ,(2016) , 10.1016/B978-0-12-394447-4.10045-8
Bianca Devitt, Wendy Liu, Renato Salemi, Rory Wolfe, John Kelly, Chin-Yuan Tzen, Alexander Dobrovic, Grant McArthur, Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma Pigment Cell & Melanoma Research. ,vol. 24, pp. 666- 672 ,(2011) , 10.1111/J.1755-148X.2011.00873.X
Anna Maria Cesinaro, Laura Schirosi, Stefania Bettelli, Mario Migaldi, Antonio Maiorana, Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz's nevi but do not predict their biological behaviour. Histopathology. ,vol. 57, pp. 515- 527 ,(2010) , 10.1111/J.1365-2559.2010.03653.X
Chris Pepper, Aneela Majid, Thet Thet Lin, Saman Hewamana, Guy Pratt, Renata Walewska, Stefan Gesk, Reiner Siebert, Simon Wagner, Ben Kennedy, Fiona Miall, Zadie A Davis, Ian Tracy, Anne C Gardiner, Paul Brennan, Robert K Hills, Martin JS Dyer, David Oscier, Chris Fegan, None, Defining the prognosis of early stage chronic lymphocytic leukaemia patients. British Journal of Haematology. ,vol. 156, pp. 499- 507 ,(2012) , 10.1111/J.1365-2141.2011.08974.X
T. Nouspikel, DNA repair in mammalian cells : Nucleotide excision repair: variations on versatility. Cellular and Molecular Life Sciences. ,vol. 66, pp. 994- 1009 ,(2009) , 10.1007/S00018-009-8737-Y
Marcia S Brose, Patricia Volpe, Michael Feldman, Madhu Kumar, Irum Rishi, Renee Gerrero, Eugene Einhorn, Meenhard Herlyn, John Minna, Andrew Nicholson, Jack A Roth, Steven M Albelda, Helen Davies, Charles Cox, Graham Brignell, Philip Stephens, P Andrew Futreal, Richard Wooster, Michael R Stratton, Barbara L Weber, None, BRAF and RAS mutations in human lung cancer and melanoma Cancer Research. ,vol. 62, pp. 6997- 7000 ,(2002)
Bruce K Armstrong, Anne Kricker, The epidemiology of UV induced skin cancer. Journal of Photochemistry and Photobiology B-biology. ,vol. 63, pp. 8- 18 ,(2001) , 10.1016/S1011-1344(01)00198-1
Roopika Menon, Mario Deng, Diana Boehm, Martin Braun, Falko Fend, Detlef Boehm, Saskia Biskup, Sven Perner, Exome Enrichment and SOLiD Sequencing of Formalin Fixed Paraffin Embedded (FFPE) Prostate Cancer Tissue International Journal of Molecular Sciences. ,vol. 13, pp. 8933- 8942 ,(2012) , 10.3390/IJMS13078933
Bjarki Stefansson, David L. Brautigan, Protein phosphatase PP6 N terminal domain restricts G1 to S phase progression in human cancer cells. Cell Cycle. ,vol. 6, pp. 1386- 1392 ,(2007) , 10.4161/CC.6.11.4276